Clinical trial
Effects of Metreleptin in Type 1 Diabetes Mellitus
NCT01268644
Study timeline
Study start (unknown)2010-09-01Date precision: month
Registry last updated2019-08-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetesunresolved
Interventions
LeptinDRUG
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
Juvenile Diabetes Research Foundationcollaborator
Amylin Pharmaceuticals, LLC.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01268644 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.